Whitehawk presents data confirming PTK7 as broadly expressed tumor target
PositiveFinancial Markets

Whitehawk has released new data confirming that PTK7 is a widely expressed tumor target, which is significant for cancer research and treatment development. This discovery could lead to more effective therapies for patients, as targeting PTK7 may improve treatment outcomes and provide new avenues for combating various cancers.
— Curated by the World Pulse Now AI Editorial System








